Stock News - CytomX Therapeutics, Inc. $CTMX
Latest Stock News for $CTMX
CytomX Therapeutics Completes $234.4 Million Offering of Common Stock and Pre-Funded Warrants
Expected Stock impact: Noticeably Positive
2026-03-21 13:50:32
CytomX Therapeutics Reports 2025 Financial Results with $76.2M Revenue and Positive Phase 1 Data
Expected Stock impact: Slightly Positive
2026-03-16 11:05:21
